BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Aerie Pharmaceuticals, Inc. (AERI) To Participate In Two Investor Conferences In March 3/3/2015 12:02:18 PM
Aerie Pharmaceuticals, Inc. (AERI) Announces Rhopressa Presentation At 2015 Meeting Of The Association For Ocular Pharmacology And Therapeutics 2/18/2015 1:40:45 PM
Aerie Pharmaceuticals, Inc. (AERI) Announces Potential Breakthroughs With New Preclinical Research 2/18/2015 10:42:04 AM
Aerie Pharmaceuticals, Inc. (AERI) To Announce Fourth Quarter And Year End 2014 Financial Results And Host Conference Call On Monday, March 2, 2015 2/17/2015 12:26:21 PM
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs 2/10/2015 7:05:24 AM
Aerie Pharmaceuticals, Inc. (AERI) To Participate In Two Investor Conferences In February 2/3/2015 12:15:32 PM
Aerie Pharmaceuticals, Inc. (AERI) Announces Acceleration Of Expected Timeline For Reporting Efficacy Results From Phase 3 Registration Trial (“Rocket 1”) Of Rhopressa™ 1/12/2015 2:33:44 PM
Aerie Pharmaceuticals, Inc. (AERI) Added To NASDAQ Biotechnology Index (NBI) 12/16/2014 10:41:47 AM
Aerie Pharmaceuticals, Inc. (AERI) Completes Enrollment In Phase 3 Registration Trial ("Rocket 1") Of Rhopressa™, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma 12/2/2014 8:56:23 AM
Aerie Pharmaceuticals, Inc. (AERI) To Present At Piper Jaffray 26th Annual Healthcare Conference 11/24/2014 10:42:07 AM
123456